9,871
Total Claims
$2.6M
Drug Cost
1,907
Beneficiaries
$1,342
Cost/Patient
Peer Comparison vs. 13,195 Dermatology providers
+11%
Cost per patient vs peers
$1,342 vs $1,209 avg
-5%
Brand preference vs peers
7.1% vs 7.5% avg
Brand vs Generic
93% generic
Brand: 699 claims · $2.1M
Generic: 9,172 claims · $500K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Risankizumab-Rzaa | 24 | $520K |
| Ruxolitinib Phosphate | 71 | $177K |
| Secukinumab | 23 | $175K |
| Apremilast | 32 | $161K |
| Dupilumab | 35 | $138K |
| Clobetasol Propionate | 737 | $85K |
| Fluocinonide | 909 | $78K |
| Efinaconazole | 53 | $71K |
| Tacrolimus | 213 | $61K |
| Ketoconazole | 1,474 | $31K |
| Ammonium Lactate | 1,105 | $29K |
| Roflumilast | 30 | $27K |
| Triamcinolone Acetonide | 1,119 | $26K |
| Pimecrolimus | 45 | $20K |
| Halobetasol Propionate | 264 | $20K |
Prescribing Profile
48
Unique Drugs
Patient Profile
71
Avg Age
69%
Female
1.24
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About